Christoph Schliemann Selected Research

Christoph Schliemann Research Topics

Disease

43	Neoplasms (Cancer) 03/2022 - 12/2007
26	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022 - 09/2006
13	Infarction (Infarctions) 06/2021 - 03/2008
6	Lymphoma (Lymphomas) 07/2021 - 03/2009
4	Leukemia 12/2021 - 09/2013
4	Thrombosis (Thrombus) 11/2021 - 03/2008
4	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 03/2009
4	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2018
4	Neoplasm Metastasis (Metastasis) 10/2018 - 07/2009
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2015
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020 - 09/2013
3	Adenocarcinoma 01/2017 - 03/2008
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2015
3	Fibrosarcoma 12/2016 - 12/2010
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 07/2017
2	Disease Progression 01/2022 - 10/2020
2	Hodgkin Disease (Hodgkin's Disease) 11/2021 - 01/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 03/2009
2	Recurrent respiratory papillomatosis 01/2021 - 11/2014
2	Acute Promyelocytic Leukemia 01/2021 - 02/2018
2	Papilloma (Papillomatosis) 01/2021 - 11/2014
2	Multiple Myeloma 01/2021 - 08/2020
2	Cytokine Release Syndrome 10/2020 - 05/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2019 - 11/2017
2	Lymphadenitis (Adenitis) 01/2019 - 12/2009
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 10/2018 - 08/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2017
2	Myeloid Sarcoma (Chloroma) 07/2017 - 09/2013
2	Melanoma (Melanoma, Malignant) 12/2016 - 10/2012
2	Hematologic Neoplasms (Hematological Malignancy) 03/2009 - 06/2008
1	Carcinogenesis 06/2022
1	Airway Obstruction (Choking) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021
1	Epstein-Barr Virus Infections 07/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2021
1	Skin Neoplasms (Skin Cancer) 05/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Necrosis 01/2021
1	Proteinuria 01/2021

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 03/2022 - 03/2008
14	Thromboplastin (Tissue Factor)IBA 06/2021 - 12/2010
9	Peptides (Polypeptides)IBA 03/2022 - 07/2009
8	CD13 Antigens (Alanine Aminopeptidase)IBA 06/2021 - 01/2014
7	AntibodiesIBA 06/2021 - 12/2009
6	AntigensIBA 07/2022 - 06/2008
6	LigandsIBA 03/2022 - 09/2006
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2014
6	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2018 - 09/2013
5	Membrane Proteins (Integral Membrane Proteins)IBA 10/2015 - 07/2009
5	Fibronectins (Fibronectin)IBA 07/2015 - 06/2008
5	Monoclonal AntibodiesIBA 09/2013 - 06/2008
4	CytokinesIBA 01/2022 - 01/2010
4	Pharmaceutical PreparationsIBA 06/2021 - 12/2016
4	Interleukin-2 (IL2)IBA 07/2015 - 12/2010
3	Therapeutic UsesIBA 11/2020 - 01/2014
3	Rituximab (Mabthera)FDA Link 07/2015 - 03/2009
3	F8 monoclonal antibodyIBA 09/2013 - 06/2008
3	Coloring Agents (Dyes)IBA 09/2013 - 12/2009
2	Azacitidine (5 Azacytidine)FDA Link 12/2021 - 01/2019
2	GTP-Binding Proteins (G-Protein)IBA 11/2021 - 12/2019
2	Calcitonin Receptors (Calcitonin Receptor)IBA 11/2021 - 12/2019
2	Neuropeptide Receptors (Neuropeptide Receptor)IBA 11/2021 - 12/2019
2	Bevacizumab (Avastin)FDA Link 01/2021 - 11/2014
2	Decitabine FDA Link 01/2021 - 01/2019
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 02/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2016
2	Immunoglobulin FragmentsIBA 01/2021 - 06/2008
2	PhosphatidylserinesIBA 01/2020 - 12/2016
2	ZincIBA 11/2017 - 01/2017
2	Peptide Hydrolases (Proteases)FDA Link 11/2017 - 01/2017
2	OsteopontinIBA 10/2012 - 05/2012
2	ProteomeIBA 04/2011 - 07/2009
2	Protein Isoforms (Isoforms)IBA 02/2010 - 12/2009
2	TenascinIBA 02/2010 - 12/2009
1	Transcription Factors (Transcription Factor)IBA 06/2022
1	Phosphotransferases (Kinase)IBA 06/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2022
1	LuciferasesIBA 03/2022
1	Codon (Codons)IBA 03/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	nitinolIBA 01/2022
1	BI 836858IBA 01/2022
1	pevonedistatIBA 12/2021
1	CPX-351IBA 10/2021
1	MagnesiumIBA 07/2021
1	Terminator Codon (Termination Codon)IBA 05/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021
1	Recombinant Fusion ProteinsIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021

Therapy/Procedure

36	Therapeutics 07/2022 - 12/2007
13	Drug Therapy (Chemotherapy) 01/2022 - 12/2010
7	Stem Cell Transplantation 11/2021 - 08/2013
4	Hematopoietic Stem Cell Transplantation 07/2021 - 05/2015
3	Radiotherapy 01/2020 - 01/2018
2	Molecular Targeted Therapy 06/2022 - 05/2019
2	Salvage Therapy 11/2021 - 10/2020
1	Stents 01/2022
1	Aftercare (After-Treatment) 01/2021